Low bone mineral density (BMD) and osteoporosis are prevalent in HIV-infected patients and were associated with HIV infection and tenofovir-containing ART.

Bianco, C., Rossetti, B., Gagliardini, R., Lamonica, S., Fanti, L., Lombardi, F., Cauda, R., Di Giambenedetto, S., De Luca, A., Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study, Abstract de <<HIV Drug Therapy Glasgow>>, (Glasgow, 02-06 November 2014 ), <<JOURNAL OF THE INTERNATIONAL AIDS SOCIETY>>, 2014; 17 (4 Suppl 3): 19816-19816. 10.7448/IAS.17.4.19816 [http://hdl.handle.net/10807/61163]

Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study

Bianco, Claudia;Rossetti, Barbara;Gagliardini, Roberta;Lombardi, F;Cauda, Roberto;Di Giambenedetto, Simona;De Luca, Andrea
2014

Abstract

Low bone mineral density (BMD) and osteoporosis are prevalent in HIV-infected patients and were associated with HIV infection and tenofovir-containing ART.
Inglese
Bianco, C., Rossetti, B., Gagliardini, R., Lamonica, S., Fanti, L., Lombardi, F., Cauda, R., Di Giambenedetto, S., De Luca, A., Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study, Abstract de <<HIV Drug Therapy Glasgow>>, (Glasgow, 02-06 November 2014 ), <<JOURNAL OF THE INTERNATIONAL AIDS SOCIETY>>, 2014; 17 (4 Suppl 3): 19816-19816. 10.7448/IAS.17.4.19816 [http://hdl.handle.net/10807/61163]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/61163
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 16
social impact